Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01845974 · ClinicalTrials.gov registry record · NA
Atrial Pressure Electrophysiology Pilot Study
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01845974 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 13 participants.
The verdict
NCT01845974, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study examined data elements of hemodynamic, electrophysiologic and electrolyte trends comparing 2 different types of catheters used during a procedure to treat medication resistant atrial fibrillation-radiofrequency catheter ablation. A high flow catheter delivers a high volume of saline during the procedure. The low flow catheter delivers a low volume of saline during the procedure. The patient will be consented and randomized to one of the 2 groups using a computer generated randomization chart. Those that are put in the low flow catheter group will be considered the experimental group. All data will be collected before and after the procedure and each patient will act as their own control within each group.
Interventions
- DEVICE ThermoCool® SF NAV Catheter
- DEVICE ThermoCool® catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01845974
The ClinicalTrials.gov registry entry for NCT01845974 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ThermoCool® SF NAV Catheter is the first listed.
NCT01845974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01845974 about?
NCT01845974 is a clinical study titled "Atrial Pressure Electrophysiology Pilot Study". This study examined data elements of hemodynamic, electrophysiologic and electrolyte trends comparing 2 different types of catheters used during a procedure to treat medication resistant atrial fibrillation-radiofrequency catheter ablation. A high flow catheter delivers a high volume of saline durin...
What is the current status of trial NCT01845974?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2013-05. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01845974?
The interventions under investigation include: ThermoCool® SF NAV Catheter (DEVICE), ThermoCool® catheter (DEVICE).
Who is sponsoring clinical trial NCT01845974?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.